Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care

被引：2
|
作者：
Parperis, Konstantinos [1 ,2 ]
机构：
[1] Univ Cyprus, Sch Med, Div Rheumatol, Internal Med, CY-1678 Nicosia, Cyprus
[2] Univ Arizona, Coll Med Phoenix, Med, Phoenix, AZ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷 / 12期
关键词：
gout; NSAIDs; treatment;
D O I：
10.1136/annrheumdis-2019-216643
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E202 / E202
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of an oral misoprostol standard-dose regimen vs a low-dose regimen for induction of labour in Papua New Guinean women: An open-label randomised controlled trial
    Bolnga, John W.
    Mola, Glen D. L.
    Totona, Catherine
    Ao, Paula
    Lufele, Elvin
    Laman, Moses
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2021, 61 (04): : 554 - 562
  • [32] Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
    Rajkumar, S. Vincent
    Jacobus, Susanna
    Callander, Natalie S.
    Fonseca, Rafael
    Vesole, David H.
    Williams, Michael E.
    Abonour, Rafat
    Siegel, David S.
    Katz, Michael
    Greipp, Philip R.
    LANCET ONCOLOGY, 2010, 11 (01): : 29 - 37
  • [33] Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial
    Bunupuradah, Torsak
    Kiertiburanakul, Sasisopin
    Avihingsanon, Anchalee
    Chetchotisakd, Ploenchan
    Techapornroong, Malee
    Leerattanapetch, Niramon
    Kantipong, Pacharee
    Bowonwatanuwong, Chureeratana
    Banchongkit, Sukit
    Klinbuayaem, Virat
    Mekviwattanawong, Sripetcharat
    Nimitvilai, Sireethorn
    Jirajariyavej, Supunnee
    Prasithsirikul, Wisit
    Munsakul, Warangkana
    Bhakeecheep, Sorakij
    Chaivooth, Suchada
    Phanuphak, Praphan
    Cooper, David A.
    Apornpong, Tanakorn
    Kerr, Stephen J.
    Emery, Sean
    Ruxrungtham, Kiat
    LANCET HIV, 2016, 3 (08): : E343 - E350
  • [34] Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial
    Bisogno, Gianni
    De Salvo, Gian Luca
    Bergeron, Christophe
    Gallego Melcon, Soledad
    Merks, Johannes H.
    Kelsey, Anna
    Martelli, Helene
    Minard-Colin, Veronique
    Orbach, Daniel
    Glosli, Heidi
    Chisholm, Julia
    Casanova, Michela
    Zanetti, Ilaria
    Devalck, Christine
    Ben-Arush, Myriam
    Mudry, Peter
    Ferman, Sima
    Jenney, Meriel
    Ferrari, Andrea
    LANCET ONCOLOGY, 2019, 20 (11): : 1566 - 1575
  • [35] Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment
    Belcher, Annabelle M.
    Cole, Thomas O.
    Greenblatt, Aaron D.
    Hoag, Stephen W.
    Epstein, David H.
    Wagner, Michael
    Billing, Amy S.
    Massey, Ebonie
    Hamilton, Kristen R.
    Kozak, Zofia K.
    Welsh, Christopher J.
    Weintraub, Eric
    Wickwire, Emerson M.
    Wish, Eric D.
    Kaptchuk, Ted J.
    Colloca, Luana
    BMJ OPEN, 2019, 9 (06):
  • [36] Effectiveness of low-dose iron treatment in non-anaemic iron-deficient women: a prospective open-label single-arm trial
    Simic, Stana
    Karczewski, Maximilian
    Klapdor, Silke
    Nowaka, Albina
    Schubert, Morton
    Moretti, Diego
    Swinkels, Dorine W.
    Beuschlein, Felix
    Saleh, Lanja
    Suter, Paolo
    Krayenbuehl, Pierre-Alexandre
    SWISS MEDICAL WEEKLY, 2023, 153
  • [37] Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial
    Pan Li
    Ying Gu
    Yawei Yang
    Lizhi Chen
    Junmei Liu
    Lihong Gao
    Yongwen Qin
    Quancai Cai
    Xianxian Zhao
    Zhuo Wang
    Liping Ma
    Scientific Reports, 6
  • [38] Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial
    Li, Pan
    Gu, Ying
    Yang, Yawei
    Chen, Lizhi
    Liu, Junmei
    Gao, Lihong
    Qin, Yongwen
    Cai, Quancai
    Zhao, Xianxian
    Wang, Zhuo
    Ma, Liping
    SCIENTIFIC REPORTS, 2016, 6
  • [39] Oral Low-Dose Naltrexone in the Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris: An Uncontrolled Open-Label Prospective Study
    Hamel, Remi K.
    Chen, Ling
    O'Connell, Cailin
    Mann, Caroline
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [40] Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study
    Altman, Roy D.
    Strand, Vibeke
    Hochberg, Marc C.
    Gibofsky, Allan
    Markenson, Joseph A.
    Hopkins, William E.
    Cryer, Byron
    Kivitz, Alan
    Nezzer, Jennifer
    Imasogie, Olaolu
    Young, Clarence L.
    POSTGRADUATE MEDICINE, 2015, 127 (05) : 517 - 528
12345